Nuclear Diagnostic Products Of Philadelphia, Inc.

Cherry Hill, NJ Doing business as Cherry Hill Pharmacy Part of Pharmalogic Holdings Corp.

UEI
QJKJD5FKTNP3
CAGE
6XCB6
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
2 Keystone Ave #200, Cherry Hill, NJ 08003, USA
Website
radiopharmacy.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Nuclear Diagnostic Products Of Philadelphia, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Netspot (gallium 68) doses Contract · 36C24426P0339 Veterans Integrated Service Network 4 $126,204
Illuccix Contract · 36C24426N0108 Veterans Integrated Service Network 4 $1,167,000
GA68 radiopharmaceutical Contract · 36C24425P0443 Veterans Integrated Service Network 4 $66,487
Illuccix Contract · 36C24425N0076 Veterans Integrated Service Network 4 $1,266,500
Illuccix Contract · 36C24424N0106 Veterans Integrated Service Network 4 $856,400

About Nuclear Diagnostic Products Of Philadelphia, Inc.

Written by GovTribe AI ·

Nuclear Diagnostic Products Of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, is a radiopharmaceutical supplier to the Department of Veterans Affairs that operates exclusively as a prime contractor under a single-award indefinite delivery contract with VA Veterans Health Administration Veterans Integrated Service Network 4. The vendor is a for-profit corporate entity and a subsidiary of Pharmalogic Holdings Corp., headquartered in Cherry Hill, New Jersey, and delivers Gallium 68 radiopharmaceutical products (ILLUCCIX and NETSPOT) for positron emission tomography imaging and nuclear medicine diagnostics supporting veteran healthcare in the northeastern United States.

Nuclear Diagnostic Products operates within NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals), with 12 federal awards carrying combined potential value of $21.1 million across the past four years. Customer concentration is absolute: 100% of awards come from VA-VHA VISN 4, with which the vendor maintains a single-award indefinite delivery contract ceiling of $4.987 million running through November 3, 2027. The vendor's primary vehicle is this IDC, under which four delivery orders have been issued carrying $12.6 million in combined potential value. A second smaller IDC (ceiling $1 million) supports two additional task orders, primarily for NETSPOT supply under small business set-aside classification. Recent award examples include a $1.167 million delivery order for ILLUCCIX issued November 4, 2025, with completion scheduled for November 3, 2026; a $1.267 million delivery order for ILLUCCIX issued November 4, 2024; and a $126,203.55 purchase order for NETSPOT doses issued June 4, 2026, under a total small business set-aside.

Award activity has contracted year over year from three awards in 2022 to one in 2026, with three awards (combined potential value $10.6 million) reaching ultimate completion inside the next twenty-four months. Only $5.2 million of the $21.1 million combined potential value has been obligated to date, reflecting the delivery-order structure of the underlying IDC. The vendor operates as a sole supplier of ILLUCCIX within VA-VHA VISN 4 and competes under both full-and-open and small business set-aside designations depending on the delivery order classification. No subcontract footprint is reported; all awards are direct prime delivery orders to VA-VHA VISN 4.

Quick answers

What is Nuclear Diagnostic Products Of Philadelphia, Inc.'s UEI?

Nuclear Diagnostic Products Of Philadelphia, Inc.'s Unique Entity ID (UEI) in SAM.gov is QJKJD5FKTNP3.

What is Nuclear Diagnostic Products Of Philadelphia, Inc.'s CAGE code?

Nuclear Diagnostic Products Of Philadelphia, Inc.'s CAGE code is 6XCB6.

What is Nuclear Diagnostic Products Of Philadelphia, Inc.'s primary NAICS code?

Nuclear Diagnostic Products Of Philadelphia, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Nuclear Diagnostic Products Of Philadelphia, Inc. located?

Nuclear Diagnostic Products Of Philadelphia, Inc.'s physical address in SAM.gov is 2 Keystone Ave #200, Cherry Hill, NJ 08003, USA.

Is Nuclear Diagnostic Products Of Philadelphia, Inc. registered in SAM.gov?

Yes. Nuclear Diagnostic Products Of Philadelphia, Inc.'s SAM.gov registration is active through December 21, 2026.

Who is Nuclear Diagnostic Products Of Philadelphia, Inc.'s parent company?

Nuclear Diagnostic Products Of Philadelphia, Inc. is part of Pharmalogic Holdings Corp.

What is Nuclear Diagnostic Products Of Philadelphia, Inc.'s most recent federal award?

Nuclear Diagnostic Products Of Philadelphia, Inc.'s most recent federal contract award is Netspot (gallium 68) doses (36C24426P0339), from Veterans Integrated Service Network 4, on June 4, 2026.

On GovTribe

See Nuclear Diagnostic Products Of Philadelphia, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login